(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

IBVIS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

IBVIS

ST13

US500000079296446

Class

42

Filing

79296446

Registration

6741536

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

47

Latest update

08/20/2024

Trademark type

Word

Nice classes

42

Filing date

08/11/2020

Registration date

05/31/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/31/2022

Last transaction

08/20/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

03

Owner location

JP

Examiner

MAJCHER HARTNETT, MEGAN K

Law office

N50

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Veritas In Silico Inc.

Representatives

Sean K. Owens Wood Herron & Evans LLP

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Designing of machinesapparatusinstrumentsmachine partssystems composed of such machinesapparatus and instruments; pharmaceuticalmedicinechemical and engineering design services; computer software designcomputer programmingmaintenance of computer software; designingprogramming and maintenance of computer software having artificial intelligence functionality; computer software designcomputer programmingmaintenance of computer software for use in scientific and technical analysis of data from artificial intelligence; computer software designcomputer programmingmaintenance of computer software for use in analysistestingscreeningdesigningdevelopment or research on nucleic acidspharmaceuticals or chemicals; computer software designcomputer programmingmaintenance of computer software for use in drug discovery screening; computer software designcomputer programmingmaintenance of computer software for analyzing and assaying messenger RNA (mRNA) substructures; computer program designcomputer programmingmaintenance of computer program for databases; computer software designcomputer programmingmaintenance of computer software for use in genome research or the development of consumer health productstreatmentspharmaceutical preparationsdiagnostic instruments or foodstuffs; information processing using computersproviding online nondownloadable software for processing of data regarding RNA and RNA-compound interaction by computers for use in developing new drugs; technical advice relating to computerscomputers for automobiles and other computers for industrial machines requiring highly specialized knowledgeskills and experiences for proper operation; scientific and technical research consultancy in the field of life information sciencenucleic acids diagnosis and drug discoveryresearch and development relating thereto; analysis and research in the field of life information science and technologyanalysis and research on target identification and validationprediction of structure and function of proteins and nucleic acids; laboratory research and development of new products for others in the field of life information sciencenucleic acids diagnosis and drug discovery; scientific and technological servicesbiochemical and biological testinginspection of medical and chemical goods for quality control purposesefficacy and quality analysis of medical and chemical productsmedical and chemical product development and research; chemical analysis and screening on chemicalschemical product quality evaluation; screening on pharmaceuticalspharmaceutical product evaluation; scientific researchtesting and analysis in the field of nucleic acidspharmaceuticalsdrug discovery and developmentmedicineschemicals and engineering; research services in the field of biological scienceisolationpurificationanalysisscreening and research on DNARNA and other biological materials; quality assessment servicesquality control and evaluation for others; testinginspection or research of pharmaceuticalscosmetics or foodstuffs; development and research on pharmaceuticals targeting messenger RNA (mRNA) substructuresproviding information and consultancy relating thereto; Scientific and technological servicestestinginspectionanalysissurveyingdevelopment and research on small molecule compoundsantisense oligonucleotides and compoundsproviding information and consultancy relating thereto; analysissurveying and development of pharmaceuticalsproviding information and consultancy relating thereto; testinginspection and research for drug development and medical research purposesproviding information and consultancy relating thereto; testing and research on biotechnology and providing information and consultancy relating thereto; medical and biological research in the nature of genomic experimentsanalysesresearchassaystestinginspection and detection of medical and biological products for efficacy and quality evaluation; consultancyadvice and providing information on medical and biological research in the nature of genomic experimentsanalysesresearchassaystestinginspection and detection of medical and biological products for efficacy and quality evaluation; testingsurveyingresearch and data analysis for research purposes in the field of biomedicinegenome biologypharmacogenomicsdiagnosticsclinical trials or bioengineering; testinginspection and research of chemicals or reagents; research and development of vaccines and medicines; research and development of vaccines and medicines; consultancy and providing information on testinginspection and research of pharmaceuticalschemicalsreagentscosmetics or foodstuffs; conducting clinical trials for others on pharmaceuticals; research on building construction or city planning; testing or research on prevention of pollution; testing or research on electricity; testing or research on civil engineering; testinginspection or research on agriculturelivestock breeding or fisheries; testing the functionality of and research on machinesapparatus and instruments; rental of measuring apparatus; rental of computers; providing computer programs on data networksproviding temporary use of non-downloadable computer software for use in research and development of nucleic acidspharmaceuticalsmedicines and chemicals; cloud computingproviding temporary use of on-line non-downloadable cloud computing software for use in research and development of nucleic acidspharmaceuticalsmedicines and chemicals; software as a service (SaaS) services featuring software for use in research and development of nucleic acidspharmaceuticalsmedicines and chemicals; electronic storage services for archiving electronic data; providing electronic data server storage services on the internet; providing temporary use of non-downloadable computer software having artificial intelligence functionality on data networks for use in research and development of nucleic acidspharmaceuticalsmedicines and chemicals; providing temporary use of online non-downloadable computer software for analysis of science and technology data based on artificial intelligence (AI) technology; providing temporary use of online non-downloadable computer software for use in analysistestingscreeningdesigningdevelopment or research of nucleic acidspharmaceuticals or chemicals; providing temporary use of online non-downloadable computer software for use in drug discovery screening; providing temporary use of online non-downloadable computer programs on data networks for analyzing and assaying messenger RNAmRNAsubstructures; providing temporary use of online non-downloadable computer programs for creatingaccessingmanaging and searching databases; providing temporary use of online non-downloadable computer software for use in genome research and the development of consumer health productstreatmentspharmaceutical preparationsdiagnostic instruments or foodstuffs; rental of laboratory apparatus and instruments

Publications

History of USPTO decisions and trademark events.

47 publications found

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

08/20/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/20/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

08/20/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

08/20/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/11/2022

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

10/11/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/11/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/11/2022

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

10/10/2022

FICS

FINAL DISPOSITION NOTICE SENT TO IB

09/15/2022

FIMP

FINAL DISPOSITION PROCESSED

09/15/2022

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

08/31/2022

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

05/31/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

05/31/2022

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

04/10/2022

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

03/23/2022

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

03/23/2022

GPNX

NOTIFICATION PROCESSED BY IB

03/21/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/15/2022

PUBO

PUBLISHED FOR OPPOSITION

03/15/2022

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

02/23/2022

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

02/23/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/23/2022

ALIE

ASSIGNED TO LIE

02/06/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/04/2022

XAEC

EXAMINER'S AMENDMENT ENTERED

02/04/2022

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

02/04/2022

GNEA

EXAMINERS AMENDMENT E-MAILED

02/04/2022

CNEA

EXAMINERS AMENDMENT -WRITTEN

02/04/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/07/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/07/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/07/2022

GPRN

NOTIFICATION OF PRIORITY ACTION E-MAILED

07/27/2021

GPRA

PRIORITY ACTION E-MAILED

07/27/2021

CPRA

PRIORITY ACTION WRITTEN

07/27/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/23/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/23/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/23/2021

RFNT

REFUSAL PROCESSED BY IB

01/15/2021

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

12/29/2020

RFRR

REFUSAL PROCESSED BY MPU

12/28/2020

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

12/15/2020

CNRT

NON-FINAL ACTION WRITTEN

12/14/2020

DOCK

ASSIGNED TO EXAMINER

12/06/2020

MAFR

APPLICATION FILING RECEIPT MAILED

10/30/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/26/2020

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

10/22/2020

Continuous trademark protection

Get notified about every new filing that threatens IBVIS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.